Feedback
FLT3 ITD and TKD Mutation Detection
3001161
Ordering Recommendation

Aid in the diagnosis and management of acute myeloid leukemia. Not intended for minimal residual disease monitoring.

Mnemonic
FLT3-PCR
Methodology
Polymerase Chain Reaction
Performed
DNA isolation: Sun-Sat
Assay:
Mon, Wed, Fri
Reported
2-7 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA) or bone marrow (EDTA). 
Specimen Preparation
Whole Blood: Transport 5 mL whole blood. (Min: 1 mL)
Bone Marrow:
Transport 3 mL bone marrow. (Min: 1 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
FFPE tumor tissue. Fresh Tissue. Clotted or grossly hemolyzed specimens. 
Remarks
 
Stability
Ambient: 24 hours; Refrigerated: 5 days; Frozen: Unacceptable 
Reference Interval
Interpretive Data
Refer to report.

Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note
Hotline History
View Hotline History
Components
Component Test Code*Component Chart NameLOINC
3001162FLT3 Source31208-2
3001163ITD Result79210-1
3001164ITD Ratio
3001165TKD Result69548-6
3001166FLT3 ITD and TKD Mutation Detection50398-7
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • FLT3 CDX
  • FLT3 D835
  • FLT3 ITD
  • FLT3 Mutant
  • FLT3 Ratio
  • FLT3 Signal Ratio
  • FLT3 TKD